Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Neurology
Published in: BMC Neurology 1/2015

Open Access 01-12-2015 | Research article

Decision-making under explicit risk is impaired in multiple sclerosis: relationships with ventricular width and disease disability

Published in: BMC Neurology | Issue 1/2015

Login to get access
Metadata
Title
Decision-making under explicit risk is impaired in multiple sclerosis: relationships with ventricular width and disease disability
Publication date
01-12-2015
Published in
BMC Neurology / Issue 1/2015
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-015-0318-0

Other articles of this Issue 1/2015

BMC Neurology 1/2015 Go to the issue

Research article

Dysferlinopathy in Switzerland: clinical phenotypes and potential founder effects

Study protocol

A study on the natural history of scanning behaviour in patients with visual field defects after stroke

Research Article

Neurocognitive functions and brain atrophy after proven neuroborreliosis: a case-control study

Research article

Factors associated with seizure occurrence and long-term seizure control in pediatric brain arteriovenous malformation: a retrospective analysis of 89 patients

Study protocol

The PANGAEA study design – a prospective, multicenter, non-interventional, long-term study on fingolimod for the treatment of multiple sclerosis in daily practice

Study protocol

A pragmatic approach to sonothrombolysis in acute ischaemic stroke: the Norwegian randomised controlled sonothrombolysis in acute stroke study (NOR-SASS)